Table 3.
NAT2 ALLELE | AD CASES (N = 45) | CONTROLS (N = 63) | OR (95% CI) |
2*4 | 20 (0.22) | 26 (0.21) | 1.00 |
2*5A | 1 (0.01) | 4 (0.03) | 0.33 (0.03, 3.14) |
2*5B | 35 (0.39) | 53 (0.42) | 0.86 (0.42, 1.77) |
2*5C | 1 (0.01) | 2 (0.02) | 0.65 (0.06, 7.69) |
2*6A | 32 (0.36) | 39 (0.31) | 1.07 (0.51, 2.25) |
2*7B | 1 (0.01) | 2 (0.02) | 0.65 (0.06, 7.69) |
TOTAL | 90 (1.00) | 126 (1.00) | - |
The number and frequency (in brackets) of NAT2 alleles in 45 AD cases and 63 controls is shown. The OR of AD to non-disease is given with 95% CI for each NAT2 allele (with NAT2*4 as the reference group).